Lenox Wealth Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$4K Buy
16
+3
+23% +$705 ﹤0.01% 580
2021
Q4
$3K Hold
13
﹤0.01% 660
2021
Q3
$3K Hold
13
﹤0.01% 598
2021
Q2
$3K Hold
13
﹤0.01% 610
2021
Q1
$3K Sell
13
-113
-90% -$22.3K ﹤0.01% 562
2020
Q4
$23K Buy
+126
New +$21.4K ﹤0.01% 294
2020
Q2
Sell
-36
Closed -$6K 622
2020
Q1
$6K Hold
36
﹤0.01% 396
2019
Q4
$7K Buy
+36
New +$7.38K ﹤0.01% 442

Other funds holding CME

Lenox Wealth Advisors's CME Position: Q1 2022 in Review

Lenox Wealth Advisors increased its CME Group (CME) stake by 23% in Q1 2022, buying an estimated $705 and bringing the position to 16 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #580.

Lenox Wealth Advisors first reported a position in CME in Q4 2019 and has held it in 8 quarters since. The position peaked at $23K in Q4 2020. 1,184 funds tracked by Wall St. Rank hold CME as of Q1 2022.

  • Lenox Wealth Advisors held 16 shares of CME Group worth $4K as of Q1 2022.
  • Lenox Wealth Advisors bought 3 CME Group shares in Q1 2022, an estimated $705.
  • CME Group made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #580 holding.
  • Lenox Wealth Advisors first reported a position in CME Group in Q4 2019 and has held it in 8 quarters since.
  • Lenox Wealth Advisors's CME Group position peaked at $23K in Q4 2020.
  • 1,184 funds tracked by Wall St. Rank held CME Group as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.